Advanced Search
Contact | Corporate | Help

A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.

Sponsors:
  • Hoffmann-La Roche
  • Genentech
Phases:
  • Phase III
IndicationsAcronym:
  • Lymphoma, B-Cell
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: bevacizumab [Avastin]
  • Drug: R-CHOP
  • Drug: Placebo
Enrollment:
1000

Additional information about NCT00486759.


SourceSolution © 2008-2012